1. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial Adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results

   • Toshiro Kuroiwa
   • Seiji Naito
   • Jyoichi Kumazawa

   Original Article Pages: 357 - 363

2. D-19575—a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport

   • J. Pohl
   • B. Bertram
   • M. Wießler

   Original Article Pages: 364 - 370

3. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II)

   • Maurizio Viale
   • Sergio Cafaggi
   • Mauro Esposito

   Original Article Pages: 371 - 376

4. Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells

   • Peter F. Lenehan
   • Peter L. Gutiérrez
   • Douglas D. Ross

   Original Article Pages: 377 - 386

5. Cytotoxic and biochemical implications of combining AZT and AG-331

   • Josie Pressacco
   • Biserka Mitrovski
   • Charles Erlichman

   Original Article Pages: 387 - 390

6. A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer

   • Etienne Chatelut
   • Christine Chevreau
   • Pierre Canal

   Original Article Pages: 391 - 396

7. A Phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors

   • Geoffrey R. Weiss
   • John G. Kuhn
   • Daniel D. Von Hoff

   Original Article Pages: 397 - 402

8. Subcellular localisation of the antitumour drug mitoxantrone and the induction of DNA damage in resistant and sensitive human colon carcinoma cells

   • Mary E. Fox
   • Paul J. Smith

   Original Article Pages: 403 - 410

9. Cyclocreatine in cancer chemotherapy

   • Beverly A. Teicher
   • Krishna Menon
   • Rima Kaddurah-Daouk

   Original Article Pages: 411 - 416

10. Population pharmacokinetics of hydroxyurea in cancer patients

    • William G. Tracewell
    • Donald L. Trump
    • Peter R. Gwilt

    Original Article Pages: 417 - 422

11. Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors

    • Devasis Chatterjee
    • Chou Jui-Tsai Liu
    • Beverly A. Teicher

    Original Article Pages: 423 - 431

12. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption

    • Bee-Lien Leu
    • Jin-ding Huang

    Original Article Pages: 432 - 436

13. 5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study

    • Geta Fried
    • Medy Tsalik
    • Nissim Haim

    Original Article Pages: 437 - 440

14. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethy1)-2-isopropyl-1,3-dioxolanelplatinum(II), a new platinum analogue, as an anticancer agent

    • Dae-Kee Kim
    • Hun-Taek Kim
    • Weon-Seon Hong

    OriginalPaper Pages: 441 - 445

15. 9th NCI-EORTC symposium on new drugs in cancer therapy

    Meeting Announcement Pages: 446 - 446